215 related articles for article (PubMed ID: 9509070)
1. Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features.
Yoshimoto K; Endo H; Tsuyuguchi M; Tanaka C; Kimura T; Iwahana H; Kato G; Sano T; Itakura M
Clin Endocrinol (Oxf); 1998 Jan; 48(1):67-72. PubMed ID: 9509070
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism.
Cetani F; Pardi E; Giovannetti A; Vignali E; Borsari S; Golia F; Cianferotti L; Viacava P; Miccoli P; Gasperi M; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2002 Apr; 56(4):457-64. PubMed ID: 11966738
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
[TBL] [Abstract][Full Text] [Related]
4. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.
Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Hum Genet; 1997 Mar; 99(3):342-9. PubMed ID: 9050920
[TBL] [Abstract][Full Text] [Related]
6. Genetic and clinical characterization of sporadic cystic parathyroid tumours.
Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Clin Endocrinol (Oxf); 2002 Feb; 56(2):261-9. PubMed ID: 11874419
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
8. Studies in a kindred with parathyroid carcinoma.
Streeten EA; Weinstein LS; Norton JA; Mulvihill JJ; White BJ; Friedman E; Jaffe G; Brandi ML; Stewart K; Zimering MB
J Clin Endocrinol Metab; 1992 Aug; 75(2):362-6. PubMed ID: 1639936
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
[TBL] [Abstract][Full Text] [Related]
11. Familial isolated primary hyperparathyroidism with double adenoma.
Kandil E; Alabbas HH; Lum YW; Tufaro AP
South Med J; 2010 Mar; 103(3):236-8. PubMed ID: 20134367
[TBL] [Abstract][Full Text] [Related]
12. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
[TBL] [Abstract][Full Text] [Related]
13. A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer.
Yamashita K; Suzuki S; Yumita W; Ikeo Y; Uehara Y; Minemura K; Sakurai A; Hashizume K
Endocr J; 2001 Aug; 48(4):453-8. PubMed ID: 11603567
[TBL] [Abstract][Full Text] [Related]
14. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.
Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
J Clin Endocrinol Metab; 1998 Jun; 83(6):2114-20. PubMed ID: 9626148
[TBL] [Abstract][Full Text] [Related]
15. Familial hyperparathyroidism: report of a case.
Abe H; Tani T; Naito H; Mekata E; Sako H; Ioka J; Kodama M
Surg Today; 1999; 29(1):63-6. PubMed ID: 9934834
[TBL] [Abstract][Full Text] [Related]
16. A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer.
Cetani F; Pardi E; Viacava P; Pollina GD; Fanelli G; Picone A; Borsari S; Gazzerro E; Miccoli P; Berti P; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2004 Jan; 60(1):99-106. PubMed ID: 14678295
[TBL] [Abstract][Full Text] [Related]
17. Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
Honda M; Tsukada T; Horiuchi T; Tanaka R; Yamaguchi K; Obara T; Miyakawa H; Yamaji T; Ishibashi M
Intern Med; 2004 Apr; 43(4):310-4. PubMed ID: 15168774
[TBL] [Abstract][Full Text] [Related]
18. Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.
Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
Clin Endocrinol (Oxf); 1999 Feb; 50(2):191-6. PubMed ID: 10396361
[TBL] [Abstract][Full Text] [Related]
19. The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred.
Cavaco BM; Barros L; Pannett AA; Ruas L; Carvalheiro M; Ruas MM; Krausz T; Santos MA; Sobrinho LG; Leite V; Thakker RV
QJM; 2001 Apr; 94(4):213-22. PubMed ID: 11294964
[TBL] [Abstract][Full Text] [Related]
20. Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism.
Pannett AA; Kennedy AM; Turner JJ; Forbes SA; Cavaco BM; Bassett JH; Cianferotti L; Harding B; Shine B; Flinter F; Maidment CG; Trembath R; Thakker RV
Clin Endocrinol (Oxf); 2003 May; 58(5):639-46. PubMed ID: 12699448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
